Chinese biotech company Beijing InnoCare Pharma Tech Co. (InnoCare) has secured a US$160 million new round of financing led by the country’s private equity investment management firm Loyal Valley Capital, according to a statement released on InnoCare’s website on Friday. Other investors including Shanghai Jianxin Capital, healthcare-focused investment firm Vivo Capital, China-focused private equity fund […]
Chinese Drugmaker InnoCare Gets $160M Investment Led By PE Firm Loyal Valley Capital appeared first on China Money Network.